©The Author(s) 2021.
World J Gastroenterol. Mar 28, 2021; 27(12): 1226-1239
Published online Mar 28, 2021. doi: 10.3748/wjg.v27.i12.1226
Published online Mar 28, 2021. doi: 10.3748/wjg.v27.i12.1226
Table 1 Recommendations for inflammatory bowel disease patients according to their risk level
| Highest risk |
| Stay home at all times and do not leave, even to buy food, medicine or to do exercises |
| Maintain attendance to infusions (only time to leave home) and the use of prescribed IBD medications |
| Stay at least 2 m (3 steps) from other people, including family members at home, whenever possible |
| Delivered products must be left outside the house by the courier |
| Anyone entering home must wash their hands thoroughly with soap for at least 20 s |
| Do not receive any visitors, unless help is needed |
| Moderate risk |
| Avoid contact with people with symptoms of COVID-19 |
| Avoid using public transportation, crowds, public spaces and meetings with friends or family |
| Home office whenever possible |
| Use smartphones or virtual technology to contact physicians or other essential services |
| Lowest risk |
| All risk groups must follow the recommendations of the World Health Organization |
| Wash hands thoroughly with soap for at least 20 s, frequently |
| Use 70% alcohol gel if soap or water is not available |
| Avoid touching the face |
| Clean objects and surfaces that are frequently touched (such as door handles and phones) |
| Stay home to help prevent the spread of the virus |
| Leave home for very limited purposes: buying food and medication, exercise once a day (running, walking or cycling) alone or with a family member, help a vulnerable person or donate blood |
| Travel for professional purposes only if strictly necessary |
| When leaving home, minimize the time spent away and keep 2 m away from others |
- Citation: Queiroz NSF, Teixeira FV, Motta MP, Chebli LA, Hino AAF, Martins CA, Quaresma AB, Silva AAPD, Damião AOMC, Saad-Hossne R, Kotze PG. Risk stratification and geographical mapping of Brazilian inflammatory bowel disease patients during the COVID-19 outbreak: Results from a nationwide survey. World J Gastroenterol 2021; 27(12): 1226-1239
- URL: https://www.wjgnet.com/1007-9327/full/v27/i12/1226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i12.1226